Barriers and facilitators of hepatitis C screening among people who inject drugs: a multi-city, mixed-methods study

Table 4 Facilitators to past year HCV testing (N = 349)

	Tested in past 12 m	Not tested in past 12 m	P*
Overall number of subjects (N = 349**)	260	89
Facilitators by code**
Health concerns for self or others	65 (15.4)	12 (12.5)	0.47
Perceived risk	15 (3.6)	3 (3.1)	0.83
Lab characteristic	15 (3.6)	3 (3.1)	0.83
Access to transportation	36 (8.6)	11 (11.5)	0.37
Mobile testing center/SEP	75 (17.8)	13 (13.5)	0.31
Adequate time	9 (2.1)	4 (4.2)	0.25
Knowledge of testing	25 (6.7)	9 (9.4)	0.22
Free testing	85 (20.2)	13 (13.5)	0.13
Access to MD/PCP	28 (6.7)	5 (5.2)	0.60
Not having to take initiative	5 (1.2)	0 (0)	0.28
Rapport with provider	10 (2.4)	2 (2.1)	0.86
Confidentiality	8 (1.9)	1 (1.0)	0.56
Motivation	5 (1.2)	1 (1.0)	0.90
Other	16 (3.8)	8 (8.3)	0.06
Nothing	24 (5.7)	11 (11.5)	0.04

All values are n (%) unless otherwise noted.
*P value from chi-squared of independence between selected facilitator and receipt of HCV test in the preceding 12 months.
**Some respondents reported more than one facilitator.

ISSN: 1477-7517